• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Conference Info
  • Contact Us
Select Page

New Faces in Big Pharma & the Rise of the Billion Dollar Deal

Oct 27, 2014 | Business, Industry Trends

M&A mania is here. Unprecedented deal values for mergers and acquisitions dominated in 2014.  Worldwide M&A was up 47% since 2013 with 95 deals valued greater than $5 billion, as reported by Reuters. Most deals were transacted in the energy,...

Recent Posts

  • The Obesity Drug Pipeline in 2026: Emerging Targets, Companies and Clinical ReadoutsAugust 17, 2026
  • Why Clinical Trial Data Belongs in Every Pharma Valuation ModelAugust 4, 2026
  • OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&DMay 13, 2026
  • Pharmaceutical Portfolio Strategy in the AI Era: Why External Intelligence MattersApril 29, 2026
  • Why AI Stalls in Pharmaceutical R&D Operations (and How to Fix It)March 31, 2026
  • Who is Winning in Innovation and How are They Balancing Risk?February 28, 2026
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2026 | All Rights Reserved | Site by Webtyde